Immunocore Holdings (IMCR) Non-Current Debt (2020 - 2026)

Immunocore Holdings (IMCR) has reported Non-Current Debt for 7 consecutive years, with $393.7 million the latest figure, recorded in Q1 2026.

• Quarterly Non-Current Debt rose 0.54% year-over-year to $393.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $393.7 million (up 0.54% YoY) and the FY2025 annual result came in at $393.1 million, up 0.54% from the prior year.
• Non-Current Debt steadied at $393.7 million in Q1 2026 per IMCR's latest filing, from $393.1 million in the prior quarter.
• Over the last five years, Non-Current Debt for IMCR reached as high as $438.1 million in Q2 2024 and fell as low as $46.3 million in Q4 2022.
• A 5-year average of $293.4 million and a median of $391.5 million in 2025 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2024 — Non-Current Debt soared 843.3% — and 2025, when it slipped 10.52%.
• Year by year, Non-Current Debt stood at $46.3 million in 2022, then increased by 3.63% to $48.0 million in 2023, then jumped by 714.42% to $391.0 million in 2024, then climbed by 0.54% to $393.1 million in 2025, then increased by 0.14% to $393.7 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $393.7 million, $393.1 million, and $392.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.